0001752724-23-214314.txt : 20230925
0001752724-23-214314.hdr.sgml : 20230925
20230925170042
ACCESSION NUMBER: 0001752724-23-214314
CONFORMED SUBMISSION TYPE: NPORT-P
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20230731
FILED AS OF DATE: 20230925
DATE AS OF CHANGE: 20230925
PERIOD START: 20231031
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: BNY Mellon ETF Trust
CENTRAL INDEX KEY: 0001493580
IRS NUMBER: 000000000
STATE OF INCORPORATION: MA
FILING VALUES:
FORM TYPE: NPORT-P
SEC ACT: 1940 Act
SEC FILE NUMBER: 811-23477
FILM NUMBER: 231276431
BUSINESS ADDRESS:
STREET 1: 240 GREENWICH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10286
BUSINESS PHONE: 212-922-6400
MAIL ADDRESS:
STREET 1: 240 GREENWICH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10286
FORMER COMPANY:
FORMER CONFORMED NAME: Dreyfus ETF Trust
DATE OF NAME CHANGE: 20100607
0001493580
S000073736
BNY Mellon Concentrated International ETF
C000230859
BNY Mellon Concentrated International ETF
BKCI
NPORT-P
1
primary_doc.xml
NPORT-P
false
0001493580
XXXXXXXX
S000073736
C000230859
BNY Mellon ETF Trust
811-23477
0001493580
549300E2C8EQYJ7B0H81
240 Greenwich Street
New York
10286
212-922-6400
BNY Mellon Concentrated International ETF
S000073736
549300X9FYRRBEHODG85
2023-10-31
2023-07-31
N
76847264.65
50474.53
76796790.12
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
27103.65000000
N
Merck KGaA
529900OAREIS0MOPTW25
Merck KGaA
000000000
11360.00000000
NS
1995962.62000000
2.599018288239
Long
EC
CORP
DE
N
1
N
N
N
Experian PLC
635400RXXHHYT1JTSZ26
Experian PLC
000000000
62024.00000000
NS
2395120.90000000
3.118777355482
Long
EC
CORP
IE
N
1
N
N
N
Dreyfus Institutional Preferred Government Money Market Fund
549300RBWL04JG8SIX57
Dreyfus Institutional Preferred Government Money Market Fund
000000000
1419793.32000000
NS
USD
1419793.32000000
1.848766488523
Long
STIV
RF
US
N
1
N
N
N
Compass Group PLC
2138008M6MH9OZ6U2T68
Compass Group PLC
000000000
140826.00000000
NS
3663380.89000000
4.770226573631
Long
EC
CORP
GB
N
1
N
N
N
L'Oreal SA
529900JI1GG6F7RKVI53
L'Oreal SA
000000000
6240.00000000
NS
2903538.21000000
3.780806730936
Long
EC
CORP
FR
N
1
N
N
N
LVMH Moet Hennessy Louis Vuitt
IOG4E947OATN0KJYSD45
LVMH Moet Hennessy Louis Vuitton SE
000000000
3616.00000000
NS
3371885.21000000
4.390659042820
Long
EC
CORP
FR
N
1
N
N
N
Novo Nordisk A/S
549300DAQ1CVT6CXN342
Novo Nordisk A/S
000000000
20698.00000000
NS
3335549.86000000
4.343345411687
Long
EC
CORP
DK
N
1
N
N
N
ASML Holding NV
724500Y6DUVHQD6OXN27
ASML Holding NV
000000000
3520.00000000
NS
2524182.52000000
3.286833363810
Long
EC
CORP
NL
N
1
N
N
N
adidas AG
549300JSX0Z4CW0V5023
adidas AG
000000000
9600.00000000
NS
1942166.03000000
2.528967717225
Long
EC
CORP
DE
N
1
N
N
N
Nestle SA
KY37LUS27QQX7BB93L28
Nestle SA
000000000
21760.00000000
NS
2666944.33000000
3.472728906810
Long
EC
CORP
CH
N
1
N
N
N
Daikin Industries Ltd
549300Y7FWSTSHMW5Y57
Daikin Industries Ltd
000000000
12800.00000000
NS
2581323.59000000
3.361238908509
Long
EC
CORP
JP
N
1
N
N
N
Air Liquide SA
969500MMPQVHK671GT54
Air Liquide SA
000000000
18656.00000000
NS
3350900.67000000
4.363334280982
Long
EC
CORP
FR
N
1
N
N
N
CLP Holdings Ltd
25490002BUTSMP94GO68
CLP Holdings Ltd
000000000
288054.00000000
NS
2343539.00000000
3.051610615935
Long
EC
CORP
HK
N
1
N
N
N
Prudential PLC
5493001Z3ZE83NGK8Y12
Prudential PLC
000000000
164444.00000000
NS
2284501.35000000
2.974735462810
Long
EC
CORP
HK
N
1
N
N
N
TotalEnergies SE
529900S21EQ1BO4ESM68
TotalEnergies SE
000000000
47901.00000000
NS
2910400.51000000
3.789742390863
Long
EC
CORP
FR
N
1
N
N
N
SAP SE
529900D6BF99LW9R2E68
SAP SE
000000000
21760.00000000
NS
2976299.07000000
3.875551393944
Long
EC
CORP
DE
N
1
N
N
N
CapitaLand Ascendas REIT
549300ILIBAEMQZK3L20
CapitaLand Ascendas REIT
000000000
1280000.00000000
NS
2704869.34000000
3.522112494250
Long
EC
CORP
SG
N
1
N
N
N
Coloplast A/S
529900NN7SOJ5QG82X67
Coloplast A/S
000000000
17120.00000000
NS
2127938.15000000
2.770868608798
Long
EC
CORP
DK
N
1
N
N
N
Shin-Etsu Chemical Co Ltd
353800PX8Q64N86H5W41
Shin-Etsu Chemical Co Ltd
000000000
80000.00000000
NS
2631146.10000000
3.426114679908
Long
EC
CORP
JP
N
1
N
N
N
CSL Ltd
529900ECSECK5ZDQTE14
CSL Ltd
000000000
12640.00000000
NS
2279811.92000000
2.968629178950
Long
EC
CORP
AU
N
1
N
N
N
TSMC
549300KB6NK5SBD14S87
Taiwan Semiconductor Manufacturing Co Ltd
874039100
24000.00000000
NS
USD
2379600.00000000
3.098567005576
Long
EC
CORP
TW
N
1
N
N
N
SGS SA
2138007JNS19JHNA2336
SGS SA
000000000
23200.00000000
NS
2246440.00000000
2.925174341909
Long
EC
CORP
CH
N
1
N
N
N
Keyence Corp
529900M7PQBS7A89DZ11
Keyence Corp
000000000
6400.00000000
NS
2868337.26000000
3.734970244873
Long
EC
CORP
JP
N
1
N
N
N
AIA Group Ltd
ZP5ILWVSYE4LJGMMVD57
AIA Group Ltd
000000000
264028.00000000
NS
2620339.69000000
3.412043245434
Long
EC
CORP
HK
N
1
N
N
N
SMC Corp
353800O40V08DOZ70X62
SMC Corp
000000000
3200.00000000
NS
1667873.33000000
2.171800836198
Long
EC
CORP
JP
N
1
N
N
N
Kone Oyj
2138001CNF45JP5XZK38
Kone Oyj
000000000
40799.00000000
NS
2092210.40000000
2.724346156565
Long
EC
CORP
FI
N
1
N
N
N
Roche Holding AG
549300U41AUUVOAAOB37
Roche Holding AG
000000000
7136.00000000
NS
2214324.41000000
2.883355419594
Long
EC
CORP
CH
N
1
N
N
N
Alimentation Couche-Tard Inc
549300OSW32RVX8CCZ87
Alimentation Couche-Tard Inc
01626P148
76001.00000000
NS
3847743.34000000
5.010291880673
Long
EC
CORP
CA
N
1
N
N
N
Hoya Corp
353800X4VR3BHEUCJB42
Hoya Corp
000000000
19200.00000000
NS
2230878.99000000
2.904911763257
Long
EC
CORP
JP
N
1
N
N
N
Amadeus IT Group SA
9598004A3FTY3TEHHN09
Amadeus IT Group SA
000000000
29419.00000000
NS
2109628.57000000
2.747027013373
Long
EC
CORP
ES
N
1
N
N
N
2023-09-19
BNY Mellon ETF Trust
James Windels
James Windels
Treasurer
XXXX
NPORT-EX
2
951981BNYM093023.htm
STATEMENT
OF
INVESTMENTS
July
31,
2023
(Unaudited)
Description
Shares
Value
($)
Common
Stocks
–
98.1%
Australia
–
3.0%
CSL
Ltd.
12,640
2,279,812
Canada
–
5.0%
Alimentation
Couche-Tard,
Inc.
76,001
3,847,743
Denmark
–
7.1%
Coloplast
A/S,
Class
B
17,120
2,127,938
Novo
Nordisk
A/S,
Class
B
20,698
3,335,550
5,463,488
Finland
–
2.7%
Kone
OYJ,
Class
B
40,799
2,092,210
France
–
16.3%
Air
Liquide
SA
18,656
3,350,901
L'Oreal
SA
6,240
2,903,538
LVMH
Moet
Hennessy
Louis
Vuitton
SE
3,616
3,371,885
TotalEnergies
SE
47,901
2,910,401
12,536,725
Germany
–
9.0%
adidas
AG
9,600
1,942,166
Merck
KGaA
11,360
1,995,963
SAP
SE
21,760
2,976,299
6,914,428
Hong
Kong
–
9.5%
AIA
Group
Ltd.
264,028
2,620,340
CLP
Holdings
Ltd.
288,054
2,343,539
Prudential
PLC
164,444
2,284,501
7,248,380
Ireland
–
3.1%
Experian
PLC
62,024
2,395,121
Japan
–
15.6%
Daikin
Industries
Ltd.
12,800
2,581,324
Hoya
Corp.
19,200
2,230,879
Keyence
Corp.
6,400
2,868,337
Shin-Etsu
Chemical
Co.
Ltd.
80,000
2,631,146
SMC
Corp.
3,200
1,667,873
11,979,559
Netherlands
–
3.3%
ASML
Holding
NV
3,520
2,524,183
Singapore
–
3.5%
CapitaLand
Ascendas
REIT
(a)
1,280,000
2,704,869
STATEMENT
OF
INVESTMENTS
(continued)
See
Notes
to
Statement
of
Investments
Description
Shares
Value
($)
Common
Stocks
–
98.1%
(continued)
Spain
–
2.8%
Amadeus
IT
Group
SA
29,419
2,109,629
Switzerland
–
9.3%
Nestle
SA
21,760
2,666,944
Roche
Holding
AG
7,136
2,214,325
SGS
SA
23,200
2,246,440
7,127,709
Taiwan
–
3.1%
Taiwan
Semiconductor
Manufacturing
Co.
Ltd.,
ADR
24,000
2,379,600
United
Kingdom
–
4.8%
Compass
Group
PLC
140,826
3,663,381
Total
Common
Stocks
(cost
$68,935,436)
75,266,837
Investment
Companies
–
1.8%
Registered
Investment
Companies
–
1.8%
Dreyfus
Institutional
Preferred
Government
Money
Market
Fund,
Institutional
Shares,
5.30%
(b)(c)
(cost
$1,419,793)
1,419,793
1,419,793
Total
Investments
(cost
$70,355,229)
99.9%
76,686,630
Cash
and
Receivables
(Net)
0.1%
110,160
Net
Assets
100.0%
76,796,790
ADR—American
Depositary
Receipt
REIT—Real
Estate
Investment
Trust
(a)
Investment
in
a
real
estate
investment
trust.
(b)
Investment
in
affiliated
issuer.
The
investment
objective
of
this
investment
company
is
publicly
available
and
can
be
found
within
the
investment
company’s
prospectus.
(c)
The
rate
shown
is
the
1-day
yield
as
of
July
31,
2023.
NOTES
TO
STATEMENT
OF
INVESTMENTS
(Unaudited)
The
Financial
Accounting
Standards
Board
(“FASB”)
Accounting
Standards
Codification
(“ASC”)
is
the
exclusive
reference
of
authoritative
U.S.
generally
accepted
accounting
principles
(“GAAP”)
recognized
by
the
FASB
to
be
applied
by
nongovernmental
entities.
Rules
and
interpretive
releases
of
the
Securities
and
Exchange
Commission
(“SEC”)
under
authority
of
federal
laws
are
also
sources
of
authoritative
GAAP
for
SEC
registrants. BNY
Mellon
Concentrated
International
ETF (the
“fund”)
is an
investment
company
and
applies
the
accounting
and
reporting
guidance
of
the
FASB
ASC
Topic
946
Financial
Services-Investment
Companies. The
fund’s
financial
statements
are
prepared
in
accordance
with
GAAP,
which
may
require
the
use
of
management
estimates
and
assumptions.
Actual
results
could
differ
from
those
estimates.
(a)
Portfolio
valuation:
The
fair
value
of
a
financial
instrument
is
the
amount
that
would
be
received
to
sell
an
asset
or
paid
to
transfer
a
liability
in
an
orderly
transaction
between
market
participants
at
the
measurement
date
(i.e.,
the
exit
price).
GAAP
establishes
a
fair
value
hierarchy
that
prioritizes
the
inputs
of
valuation
techniques
used
to
measure
fair
value.
This
hierarchy
gives
the
highest
priority
to
unadjusted
quoted
prices
in
active
markets
for
identical
assets
or
liabilities
(Level
1
measurements)
and
the
lowest
priority
to
unobservable
inputs
(Level
3
measurements).
Additionally,
GAAP
provides
guidance
on
determining
whether
the
volume
and
activity
in
a
market
has
decreased
significantly
and
whether
such
a
decrease
in
activity
results
in
transactions
that
are
not
orderly.
GAAP
requires
enhanced
disclosures
around
valuation
inputs
and
techniques
used
during
annual
and
interim
periods.
Various
inputs
are
used
in
determining
the
value
of
the
fund’s
investments
relating
to
fair
value
measurements.
These
inputs
are
summarized
in
the
three
broad
levels
listed
below:
Level
1
—
unadjusted
quoted
prices
in
active
markets
for
identical
investments.
Level
2
—
other
significant
observable
inputs
(including
quoted
prices
for
similar
investments,
interest
rates,
prepayment
speeds,
credit
risk,
etc.).
Level
3
—
significant
unobservable
inputs
(including
the
fund’s
own
assumptions
in
determining
the
fair
value
of
investments).
The
inputs
or
methodology
used
for
valuing
securities
are
not
necessarily
an
indication
of
the
risk
associated
with
investing
in
those
securities.
Changes
in
valuation
techniques
may
result
in
transfers
in
or
out
of
an
assigned
level
within
the
disclosure
hierarchy.
Valuation
techniques
used
to
value
the
fund’s
investments
are
as
follows:
NOTES
TO
STATEMENT
OF
INVESTMENTS
(Unaudited)
(continued)
BNY
Mellon
ETF
Trust’s
(the
“Trust”) Board
of
Trustees
(the
“Board”)
has
designated
the
Adviser
as
the
fund’s
valuation
designee
to
make
all
fair
value
determinations
with
respect
to
the
fund’s
portfolio
of
investments,
subject
to
the
Board’s
oversight
and
pursuant
to
Rule
2a-5
under
the
Act.
Investments
in
equity
securities,
including
ETFs
(but
not
including
investments
in
other
open-end
registered
investment
companies)
generally
are
valued
at
the
last
sales
price
on
the
day
of
valuation
on
the
securities
exchange
or
national
securities
market
on
which
such
securities
primarily
are
traded.
Securities
listed
on
the
National
Association
of
Securities
Dealers
Automated
Quotation
System
(“NASDAQ”)
for
which
market
quotations
are
available
will
be
valued
at
the
official
closing
price.
If
there
are
no
transactions
in
a
security,
or
no
official
closing
prices
for
a
NASDAQ
market-listed
security
on
that
day,
the
security
will
be
valued
at
the
average
of
the
most
recent
bid
and
asked
prices.
Bid
price
is
used
when
no
asked
price
is
available.
Open
short
positions
for
which
there
is
no
sale
price
on
a
given
day
are
valued
at
the
lowest
asked
price.
Registered
investment
companies
that
are
not
traded
on
an
exchange
are
valued
at
their
net
asset
value.
All
of
the
preceding
securities
are
generally
categorized
within
Level
1
of
the
fair
value
hierarchy.
When
market
quotations
or
official
closing
prices
are
not
readily
available,
or
are
determined
not
to
reflect
fair
value
accurately,
they are
valued
at
fair
value
as
determined
in
good
faith
based
on
procedures
approved
by
the
Board.
Fair
value
of
investments
may
be
determined
by
valuation
designee
using
such
information
as
it
deems
appropriate
under
the
circumstances.
Certain
factors
may
be
considered
when
fair
valuing
investments
such
as:
fundamental
analytical
data,
the
nature
and
duration
of
restrictions
on
disposition,
an
evaluation
of
the
forces
that
influence
the
market
in
which
the
securities
are
purchased
and
sold,
and
public
trading
in
similar
securities
of
the
issuer
or
comparable
issuers.
These
securities
are
either
categorized
within
Level
2
or
3
of
the
fair
value
hierarchy
depending
on
the
relevant
inputs
used.
For
securities
where
observable
inputs
are
limited,
assumptions
about
market
activity
and
risk
are
used
and
are
generally
categorized
within
Level
3
of
the
fair
value
hierarchy.
Investments
denominated
in
foreign
currencies
are
translated
to
U.S.
dollars
at
the
prevailing
rates
of
exchange.
The
table
below
summarizes
the
inputs
used
as
of July
31,
2023
in
valuing
the
fund’s
investments:
Fair
Value
Measurements
Additional
investment
related
disclosures
are
hereby
incorporated
by
reference
to
the
annual
and
semi-annual
reports
previously
filed
with
the
SEC
on
Form
N-CSR.
At July
31,
2023,
accumulated
net
unrealized
appreciation on
investments
was
$6,331,401,
consisting
of
gross
appreciation
of
$7,652,115
and
gross
depreciation
of
$1,320,714.
At
July
31,
2023,
the
cost
of
investments
for
federal
income
tax
purposes
was
substantially
the
same
as
the
cost
for
financial
reporting
purposes
(see
the
Statement
of
Investments).
Level
1
-
Unadjusted
Quoted
Prices
Level
2
-
Other
Significant
Observable
Inputs
Level
3
-
Significant
Unobservable
Inputs
Total
Assets
($)
Investments
In
Securities:
†
Common
Stocks
75,266,837
—
—
75,266,837
Investment
Companies
1,419,793
—
—
1,419,793
†
See
Statement
of
Investments
for
additional
detailed
categorizations,
if
any.